earnings
AR
NASDAQ · ARQT
Arcutis Biotherapeutics, Inc.
Healthcare · Biotechnology
$23.38
Down-$0.46 (-1.93%)
Updated Sep 11, 2026, 10:10 AM
SID Score
4.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.3B
- P/E ratio
- -214.29
- Dividend yield
- 0.00%
- 52-week range
- $19.30 – $29.84
- Volume
- 1.79M
- Avg. volume
- 1.63M
Price performance
ARQT price history
1M range · 20 trading sessions · Daily adjusted prices
ARQT closed at $23.38 after 20 trading sessions, down 9.49% for the selected period.
- Last close
- $23.38
- Period change
- -9.49%
- Period low
- $23.38
- Period high
- $26.54
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $23.70 | $23.84 | $23.25 | $23.38 | 1.79M |
| Sep 9, 2026 | $24.05 | $24.46 | $23.74 | $23.84 | 2.31M |
| Sep 8, 2026 | $24.84 | $25.13 | $24.09 | $24.39 | 4.56M |
| Sep 4, 2026 | $23.27 | $24.02 | $23.27 | $23.90 | 1.63M |
| Sep 3, 2026 | $24.13 | $24.13 | $23.47 | $23.66 | 1.12M |
| Sep 2, 2026 | $23.95 | $24.45 | $23.40 | $23.85 | 1.95M |
| Sep 1, 2026 | $23.79 | $24.11 | $23.54 | $23.75 | 1.1M |
| Aug 31, 2026 | $23.75 | $24.07 | $23.21 | $23.97 | 1.52M |
| Aug 28, 2026 | $24.60 | $24.88 | $23.74 | $23.78 | 1.54M |
| Aug 27, 2026 | $24.95 | $25.15 | $24.60 | $24.87 | 2.2M |
| Aug 26, 2026 | $24.85 | $25.495 | $24.45 | $25.14 | 1.91M |
| Aug 25, 2026 | $25.01 | $25.34 | $24.745 | $24.86 | 1.19M |
| Aug 24, 2026 | $24.80 | $25.21 | $24.49 | $24.78 | 1.13M |
| Aug 21, 2026 | $25.49 | $25.67 | $24.7332 | $25.08 | 2.16M |
| Aug 20, 2026 | $26.50 | $26.56 | $24.53 | $25.35 | 3.29M |
| Aug 19, 2026 | $27.00 | $27.19 | $26.37 | $26.46 | 1.03M |
| Aug 18, 2026 | $25.51 | $26.71 | $25.49 | $26.54 | 1.97M |
| Aug 17, 2026 | $26.20 | $26.341 | $25.51 | $25.61 | 1.71M |
| Aug 14, 2026 | $25.39 | $26.235 | $25.28 | $26.19 | 1.11M |
| Aug 13, 2026 | $26.57 | $26.65 | $25.765 | $25.83 | 1.59M |
Latest ARQT news
The latest Smart Investors Daily articles mentioning ARQT.
Stock researchMarket Activity · Options
Loading stock research…